Replies to post #80494 on Bioelectronics Corp (BIEL)

[Simpsonly]

Because I believe the FDA approval of BIEL's 510(K) application for Clearance for OTC sales of ActiPatch is in its final stages and being well managed by BIEL and its legal counsel, I am focused only on the status and what and when of the British government's NHS addition of RecoveryRx to its universal healthcare tariff in the UK.

That would be a huge accomplishment, as B. Braun is already adding 2 RecoveryRx devices to every orthopaedic surgical kit it is supplying into UK hospitals. We know that numerous chemists in the UK have been adding the RecoveryRx SKU to their offerings. A significant step! British Tsunami